Huntington's disease is an inherited disease that causes degeneration of nerve cells in the central nervous system (CNS). The disease has a broad impact on functional abilities of the human and usually results in movement and thinking disabilities. Most people with Huntington's disease develop signs and symptoms in their age of 30 to 40. When disease begins before age 20, the condition is known as juvenile Huntington's disease.
The global Huntingtons Disease Therapeutics market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Huntingtons Disease Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Huntingtons Disease Therapeutics market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Auspex Pharmaceuticals
Alnylam Pharmaceuticals
Intellect Neurosciences Incorporation
H. Lundbeck
Prana Biotechnology Limited
Raptor Pharmaceuticals
Sangamo Biosciences
Teva Pharmaceutical Industries
Trophos SA
Valeant Pharmaceuticals International
Vertex Pharmaceuticals
Roche
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Antidopaminergics
Anticonvulsants
Antipsychotics
Antidepressants
Segment by Application
Hosptial
Clinic
Research
Table of Contents Executive Summary 1 Huntingtons Disease Therapeutics Market Overview 1.1 Product Overview and Scope of Huntingtons Disease Therapeutics 1.2 Huntingtons Disease Therapeutics Segment by Type1.2.1 Global Huntingtons Disease Therapeutics Production Growth Rate Comparison by Type (2014-2025) 1.2.2 Antidopaminergics 1.2.3 Anticonvulsants 1.2.4 Antipsychotics 1.2.5 Antidepressants 1.3 Huntingtons Disease Therapeutics Segment by Application1.3.1 Huntingtons Disease Therapeutics Consumption Comparison by Application (2014-2025) 1.3.2 Hosptial 1.3.3 Clinic 1.3.4 Research 1.4 Global Huntingtons Disease Therapeutics Market by Region1.4.1 Global Huntingtons Disease Therapeutics Market Size Region 1.4.2 North America Status and Prospect (2014-2025) 1.4.3 Europe Status and Prospect (2014-2025) 1.4.4 China Status and Prospect (2014-2025) 1.4.5 Japan Status and Prospect (2014-2025) 1.5 Global Huntingtons Disease Therapeutics Market Size1.5.1 Global Huntingtons Disease Therapeutics Revenue (2014-2025) 1.5.2 Global Huntingtons Disease Therapeutics Production (2014-2025) 2 Global Huntingtons Disease Therapeutics Market Competition by Manufacturers 2.1 Global Huntingtons Disease Therapeutics Production Market Share by Manufacturers (2014-2019) 2.2 Global Huntingtons Disease Therapeutics Revenue Share by Manufacturers (2014-2019) 2.3 Global Huntingtons Disease Therapeutics Average Price by Manufacturers (2014-2019) 2.4 Manufacturers Huntingtons Disease Therapeutics Production Sites, Area Served, Product Types 2.5 Huntingtons Disease Therapeutics Market Competitive Situation and Trends2.5.1 Huntingtons Disease Therapeutics Market Concentration Rate 2.5.2 Huntingtons Disease Therapeutics Market Share of Top 3 and Top 5 Manufacturers 2.5.3 Mergers & Acquisitions, Expansion 3 Global Huntingtons Disease Therapeutics Production Market Share by Regions 3.1 Global Huntingtons Disease Therapeutics Production Market Share by Regions 3.2 Global Huntingtons Disease Therapeutics Revenue Market Share by Regions (2014-2019) 3.3 Global Huntingtons Disease Therapeutics Production, Revenue, Price and Gross Margin (2014-2019) 3.4 North America Huntingtons Disease Therapeutics Production3.4.1 North America Huntingtons Disease Therapeutics Production Growth Rate (2014-2019) 3.4.2 North America Huntingtons Disease Therapeutics Production, Revenue, Price and Gross Margin (2014-2019) 3.5 Europe Huntingtons Disease Therapeutics Production3.5.1 Europe Huntingtons Disease Therapeutics Production Growth Rate (2014-2019) 3.5.2 Europe Huntingtons Disease Therapeutics Production, Revenue, Price and Gross Margin (2014-2019) 3.6 China Huntingtons Disease Therapeutics Production (2014-2019)3.6.1 China Huntingtons Disease Therapeutics Production Growth Rate (2014-2019) 3.6.2 China Huntingtons Disease Therapeutics Production, Revenue, Price and Gross Margin (2014-2019) 3.7 Japan Huntingtons Disease Therapeutics Production (2014-2019)3.7.1 Japan Huntingtons Disease Therapeutics Production Growth Rate (2014-2019) 3.7.2 Japan Huntingtons Disease Therapeutics Production, Revenue, Price and Gross Margin (2014-2019) 4 Global Huntingtons Disease Therapeutics Consumption by Regions 4.1 Global Huntingtons Disease Therapeutics Consumption by Regions 4.2 North America Huntingtons Disease Therapeutics Consumption (2014-2019) 4.3 Europe Huntingtons Disease Therapeutics Consumption (2014-2019) 4.4 China Huntingtons Disease Therapeutics Consumption (2014-2019) 4.5 Japan Huntingtons Disease Therapeutics Consumption (2014-2019) 5 Global Huntingtons Disease Therapeutics Production, Revenue, Price Trend by Type 5.1 Global Huntingtons Disease Therapeutics Production Market Share by Type (2014-2019) 5.2 Global Huntingtons Disease Therapeutics Revenue Market Share by Type (2014-2019) 5.3 Global Huntingtons Disease Therapeutics Price by Type (2014-2019) 5.4 Global Huntingtons Disease Therapeutics Production Growth by Type (2014-2019) 6 Global Huntingtons Disease Therapeutics Market Analysis by Applications 6.1 Global Huntingtons Disease Therapeutics Consumption Market Share by Application (2014-2019) 6.2 Global Huntingtons Disease Therapeutics Consumption Growth Rate by Application (2014-2019) 7 Company Profiles and Key Figures in Huntingtons Disease Therapeutics Business 7.1 Auspex Pharmaceuticals7.1.1 Auspex Pharmaceuticals Huntingtons Disease Therapeutics Production Sites and Area Served 7.1.2 Huntingtons Disease Therapeutics Product Introduction, Application and Specification 7.1.3 Auspex Pharmaceuticals Huntingtons Disease Therapeutics Production, Revenue, Price and Gross Margin (2014-2019) 7.1.4 Main Business and Markets Served 7.2 Alnylam Pharmaceuticals7.2.1 Alnylam Pharmaceuticals Huntingtons Disease Therapeutics Production Sites and Area Served 7.2.2 Huntingtons Disease Therapeutics Product Introduction, Application and Specification 7.2.3 Alnylam Pharmaceuticals Huntingtons Disease Therapeutics Production, Revenue, Price and Gross Margin (2014-2019) 7.2.4 Main Business and Markets Served 7.3 Intellect Neurosciences Incorporation7.3.1 Intellect Neurosciences Incorporation Huntingtons Disease Therapeutics Production Sites and Area Served 7.3.2 Huntingtons Disease Therapeutics Product Introduction, Application and Specification 7.3.3 Intellect Neurosciences Incorporation Huntingtons Disease Therapeutics Production, Revenue, Price and Gross Margin (2014-2019) 7.3.4 Main Business and Markets Served 7.4 H. Lundbeck7.4.1 H. Lundbeck Huntingtons Disease Therapeutics Production Sites and Area Served 7.4.2 Huntingtons Disease Therapeutics Product Introduction, Application and Specification 7.4.3 H. Lundbeck Huntingtons Disease Therapeutics Production, Revenue, Price and Gross Margin (2014-2019) 7.4.4 Main Business and Markets Served 7.5 Prana Biotechnology Limited7.5.1 Prana Biotechnology Limited Huntingtons Disease Therapeutics Production Sites and Area Served 7.5.2 Huntingtons Disease Therapeutics Product Introduction, Application and Specification 7.5.3 Prana Biotechnology Limited Huntingtons Disease Therapeutics Production, Revenue, Price and Gross Margin (2014-2019) 7.5.4 Main Business and Markets Served 7.6 Raptor Pharmaceuticals7.6.1 Raptor Pharmaceuticals Huntingtons Disease Therapeutics Production Sites and Area Served 7.6.2 Huntingtons Disease Therapeutics Product Introduction, Application and Specification 7.6.3 Raptor Pharmaceuticals Huntingtons Disease Therapeutics Production, Revenue, Price and Gross Margin (2014-2019) 7.6.4 Main Business and Markets Served 7.7 Sangamo Biosciences7.7.1 Sangamo Biosciences Huntingtons Disease Therapeutics Production Sites and Area Served 7.7.2 Huntingtons Disease Therapeutics Product Introduction, Application and Specification 7.7.3 Sangamo Biosciences Huntingtons Disease Therapeutics Production, Revenue, Price and Gross Margin (2014-2019) 7.7.4 Main Business and Markets Served 7.8 Teva Pharmaceutical Industries7.8.1 Teva Pharmaceutical Industries Huntingtons Disease Therapeutics Production Sites and Area Served 7.8.2 Huntingtons Disease Therapeutics Product Introduction, Application and Specification 7.8.3 Teva Pharmaceutical Industries Huntingtons Disease Therapeutics Production, Revenue, Price and Gross Margin (2014-2019) 7.8.4 Main Business and Markets Served 7.9 Trophos SA7.9.1 Trophos SA Huntingtons Disease Therapeutics Production Sites and Area Served 7.9.2 Huntingtons Disease Therapeutics Product Introduction, Application and Specification 7.9.3 Trophos SA Huntingtons Disease Therapeutics Production, Revenue, Price and Gross Margin (2014-2019) 7.9.4 Main Business and Markets Served 7.10 Valeant Pharmaceuticals International7.10.1 Valeant Pharmaceuticals International Huntingtons Disease Therapeutics Production Sites and Area Served 7.10.2 Huntingtons Disease Therapeutics Product Introduction, Application and Specification 7.10.3 Valeant Pharmaceuticals International Huntingtons Disease Therapeutics Production, Revenue, Price and Gross Margin (2014-2019) 7.10.4 Main Business and Markets Served 7.11 Vertex Pharmaceuticals 7.12 Roche 8 Huntingtons Disease Therapeutics Manufacturing Cost Analysis 8.1 Huntingtons Disease Therapeutics Key Raw Materials Analysis8.1.1 Key Raw Materials 8.1.2 Price Trend of Key Raw Materials 8.1.3 Key Suppliers of Raw Materials 8.2 Proportion of Manufacturing Cost Structure 8.3 Manufacturing Process Analysis of Huntingtons Disease Therapeutics 8.4 Huntingtons Disease Therapeutics Industrial Chain Analysis 9 Marketing Channel, Distributors and Customers 9.1 Marketing Channel9.1.1 Direct Marketing 9.1.2 Indirect Marketing 9.2 Huntingtons Disease Therapeutics Distributors List 9.3 Huntingtons Disease Therapeutics Customers 10 Market Dynamics 10.1 Market Trends 10.2 Opportunities 10.3 Market Drivers 10.4 Challenges 10.5 Influence Factors 11 Global Huntingtons Disease Therapeutics Market Forecast 11.1 Global Huntingtons Disease Therapeutics Production, Revenue Forecast11.1.1 Global Huntingtons Disease Therapeutics Production Growth Rate Forecast (2019-2025) 11.1.2 Global Huntingtons Disease Therapeutics Revenue and Growth Rate Forecast (2019-2025) 11.1.3 Global Huntingtons Disease Therapeutics Price and Trend Forecast (2019-2025) 11.2 Global Huntingtons Disease Therapeutics Production Forecast by Regions (2019-2025)11.2.1 North America Huntingtons Disease Therapeutics Production, Revenue Forecast (2019-2025) 11.2.2 Europe Huntingtons Disease Therapeutics Production, Revenue Forecast (2019-2025) 11.2.3 China Huntingtons Disease Therapeutics Production, Revenue Forecast (2019-2025) 11.2.4 Japan Huntingtons Disease Therapeutics Production, Revenue Forecast (2019-2025) 11.3 Global Huntingtons Disease Therapeutics Consumption Forecast by Regions (2019-2025)11.3.1 North America Huntingtons Disease Therapeutics Consumption Forecast (2019-2025) 11.3.2 Europe Huntingtons Disease Therapeutics Consumption Forecast (2019-2025) 11.3.3 China Huntingtons Disease Therapeutics Consumption Forecast (2019-2025) 11.3.4 Japan Huntingtons Disease Therapeutics Consumption Forecast (2019-2025) 11.4 Global Huntingtons Disease Therapeutics Production, Revenue and Price Forecast by Type (2019-2025) 11.5 Global Huntingtons Disease Therapeutics Consumption Forecast by Application (2019-2025) 12 Research Findings and Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Author List
Summary: Get latest Market Research Reports on Huntingtons Disease Therapeutics. Industry analysis & Market Report on Huntingtons Disease Therapeutics is a syndicated market report, published as Global Huntingtons Disease Therapeutics Market Research Report 2019. It is complete Research Study and Industry Analysis of Huntingtons Disease Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
Last updated on 08 March, 2019